Introduction

In a groundbreaking development for those suffering from sleep apnoea, a pioneering app-controlled implant has been introduced in the UK, significantly enhancing overnight breathing for millions. This innovative device, which stimulates the nerves in the tongue, offers a promising alternative to traditional treatments.

Overview of Sleep Apnoea

Sleep apnoea, a disorder that causes breathing disruptions during sleep, is believed to impact around 8 million people across the UK. The most prevalent form, obstructive sleep apnoea, occurs when the throat's walls become relaxed and obstruct airflow. Symptoms often include loud snoring, choking sounds during sleep, and interrupted rest, leading to daytime fatigue.

Successful Implantation Procedures

This month, medics at University College London Hospitals NHS foundation trust (UCLH) successfully completed the implantation of Nyxoah’s Genio device in a three-hour procedure. Among the first patients was 63-year-old Natalie Boller, who reported feeling revitalized merely days post-operation. She eagerly anticipates getting the device activated soon, which could significantly improve her energy levels and activity.

Advancements in Treatment Options

UCLH has made history by becoming the first UK center to provide sleep apnoea patients with a choice between two advanced nerve stimulators—the Genio and Inspire implants. Both of these devices work by stimulating the hypoglossal nerve, which regulates tongue movement, thus serving as a viable alternative to Continuous Positive Airway Pressure (CPAP) machines. While CPAP therapy, the standard treatment for sleep apnoea, involves wearing a mask that delivers pressurized air during sleep, many patients find it uncomfortable and challenging to use consistently.

Surgeon Insights

Consultant ENT and sleep surgeon Ryan Chin Taw Cheong expressed optimism about the future of this technology, stating, “I’m very optimistic about the way things are moving, and I’m hoping that we will be able to make this technology and implant more available for the right patients.”

Procedure Details

During the procedure for the device, surgeons make a small incision beneath the chin and utilize a microscope to accurately locate the nerves responsible for tongue protrusion. The Genio stimulator is equipped with an external chip that adheres to the chin using an adhesive patch during sleep hours. Patients can easily remove the patch during the day to recharge the chip, as well as monitor their sleep data and adjust stimulation levels through a user-friendly smartphone app.

Eligibility Criteria

Eligibility for the Genio and Inspire implants is contingent on patients having moderate to severe sleep apnoea, a body mass index (BMI) of under 35, and prior attempts at CPAP therapy, which highlights the importance of preliminary treatment options.

Looking Ahead

Cheong further noted, “We’re hoping to drive this field forward and offer these treatment options, ensuring that patients visiting our clinics leave with confidence, knowing they can access the best treatments for sleep apnoea available worldwide.”

Conclusion

As the UK embraces this transformative approach to treating sleep apnoea, it raises hopes for many who have long struggled with the condition, marking a significant milestone in sleep disorder management and patient care.